Drug Industry, Having Long Smiled on G.O.P., Now Splits Donations Equally
October 14th, 2008 by
Lobbyists and executives say the swing reflects the fact that drug companies’ fortunes depend more than ever on Democrats in power.
Posted in Campaign Finance, Pfizer Inc|PFE|NYSE, Johnson & Johnson Inc, Pharmaceutical Research and Manufacturers of America, Amgen Inc|AMGN|NASDAQ, Drugs (Pharmaceuticals), American Medical Assn, Health Insurance and Managed Care, Democratic Party, Republican Party, Lobbying and Lobbyists, United States Politics and Government, Presidential Election of 2008